重庆欢乐生肖

华人眼科学家参与欧盟“地平线2020”计划,有望攻破视网膜疤痕治疗历史难题

发布日期:2018-09-10 视网膜 爱尔眼科 徐和平

  LAONIANHUANGBANBIANXING、TANGNIAOBINGYINQIDESHIWANGMOBINGBIAN、SHIWANGMOTUOLUODENGYANDIJIBINGHUIDAOZHIXUEGUANXIANWEIMO(BAHEN)DECHANSHENG,ZHEIZHONGBAHENDECHANSHENGJIANGYANZHONGYINGXIANGSHIJUEZHILIANGSHENZHIZHIMANG,SHIDAOZHIYANDIJIBINGZHIMANGLVJUGAOBUXIADEZHONGYAOYUANYINZHIYI。QUANQIUKEXUEJIEZAIZHEIFANGMIANDEYANJIUYIZHIXIANYOUJINZHAN。

  9月5日,在中华医学会第二十四次全国眼科学术大会期间,爱尔眼科上市十年之际,中南大学爱尔眼科学院博士生导师、英国贝尔法斯特女王大学眼免疫学徐和平教授透露,由他作为首席科学家之一主导的欧盟“地平线2020”重点研发计划欧科瑟(OcuTher)项目,有望攻破人类历史在视网膜疤痕化药物治疗的困境,这一研究成果或将造福全球数亿名眼底病患者。

  视网膜如感光底片

  损坏严重可致盲

  欧盟“地平线2020”研发项目是欧洲国际型大科学工程项目,整合了世界顶尖的科学家及团队,重庆欢乐生肖旨在将基础研究领域的高端、前沿和有突破性的科学发现转化成产品,推动世界经济发展。欧科瑟(OcuTher)项目作为欧盟“地平线2020”居里夫人行动研发项目之一,获393万欧元资金支持,于2017年正式启动。该项目执行期长达四年,目前已进入科研成果呼之欲出的重要阶段。

  OUKESE(OcuTher)XIANGMUSHIOUMENG“DIPINGXIAN2020”JULIFURENXINGDONGYANFAXIANGMUZHIYI

  欧科瑟(OcuTher)项目从全球遴选9个顶级科研单位参与,研究方向包括生物材料、药物学及实验眼科3个方向,徐和平教授是实验眼科方向的首席科学家。作为一位眼科华人首席科学家,其带领的团队将致力于为致盲性视网膜疾病开发新药并培养眼科药物开发的高端研发人才。

  WEIYURENYANYANDIDESHIWANGMOJIUXIANGZHAOXIANGJIDEGANGUANGDIPIAN,DANGSHIWANGMOYOUYANZHENG、POSUNSHENZHITUOLUOSHI,JIANGYANZHONGYINGXIANGRENYANDESHIJUECHENGXIANG,SHIWANGMOZAISUNSHANGJISUIHOUDEXIUFUGUOCHENGZHONGRONGYICHANSHENGXUEGUANXINGBAHENMO,HUIDAOZHIYONGJIUXINGSHILISANGSHI。CHANGJIANDESHIWANGMOJIBINGBAOKUOLAONIANHUANGBANBIANXING、TANGNIAOBINGSHIWANGMOBINGBIAN、SHIWANGMOTUOLUOJIGAODUJINSHIYINFADESHIWANGMOBIANXINGJITUOLUODENG。GUOJIYANKEKEXUEYUANYUANSHIWANGNINGLIJIAOSHOUQIANGDIAO,YANDIBINGTUOYANBUDE,YISHIXINGLAONIANHUANGBANBIANXINGWEILI,JIXINGJINZHANQIKEZAIDUANDUANLIANGSANGEYUENEIJIUZAOCHENGSHIMINGDEYANZHONGHOUGUO。

  目前全球眼底病发病率高居不下,中国伴随着老龄化的到来,更是将迎来眼底病发病的高发期。重庆欢乐生肖据统计,全球黄斑变性患者多达3000万,我国50岁以上人群的黄斑变性患病率为15.5%,患者总数超过400万。国际糖尿病联盟数据显示,2017年全球约4.25亿成人患糖尿病。我国糖尿病患者超1.1亿人,且糖尿病视网膜病变在糖尿病患者中的患病率高达24.7%~37.5%,按此推算我国糖尿病视网膜病变患者约2700万人。且随着我国近视人口的急剧增加,高度近视人数也随之水涨船高,已多达3000万,且高度近视的致盲率高达1%-2%。

  联合材料、药理、眼科

  多维度攻坚眼后段给药问题

重庆欢乐生肖  GUANYUSHIWANGMOJIBINGDEYAOWUZHILIAOYIZHISHIQUANQIUYANDIBINGYANJIUXIANGMUZHONGDEZHONGDIANHENANDIAN,BINGQIEDADUOSHUSHIWANGMOJIBINGRENGRANMEIYOUYOUXIAODEYAOLIZHILIAOFANGFA,ZHEIHEQUEFAYANNEIYAOXINGKONGZHISHOUDUAN,QUEFASONGYAORUYANTUJING,YIJIQUEFAYONGYUYANBUYAOWUKAIFADEXITONGGONGJUYOUMIQIEGUANXI。JIUHAOBIYOUXIEYAOWUZAI3-4DUDEWENDUXIABIJIAOWENDING,DANDANGZHURUYANNEI,WENDUSHENGZHI36-37DUSHI,YAOWUJIUHUIHENKUAIJIANGJIE,SHIQUZHILIAOXIAOGUO。

重庆欢乐生肖  OUKESE(OcuTher)XIANGMUDEZONGFUZEREN,DONGFENLANDAXUE、HEERXINJIDAXUESHENGWUZHIYAOXUEJIAOSHOUArtoUrttiHAIZHICHU,“YOUYUYANJINGDETESHUBAOHUJIEGOUKEFANGZHIYANYAOSHUIJINRUSHIWANGMO,ERQIEBINGFEISUOYOUYAOWUDOUKEYITONGGUOYANNEIZHUSHEJIYAO,ZHEIYEJIADALESHIWANGMOJIBINGYAOWUZHILIAODENANDU。”

  MUQIAN,LAONIANHUANGBANBIANXING、TANGNIAOBINGYINQIDESHIWANGMOBINGBIANDENGYANDIJIBINGDUOCAIYONGYANNEIZHUYAOFANGSHIJINXINGZHILIAOHEKONGZHI,ZHEIBIXUZAIZHUANYEYANKEYILIAOJIGOUYOUZHUANYEDEYANKEYISHENGJINXING,DUIHUANZHEERYANSHIFENBUBIAN。XUHEPINGBIAOSHI,“ZHONGQINGHUANLESHENGXIAOTONGGUOZHENGHEYANBUYAOWUKAIFAJILINCHUANGQIANQIDE3GEZHONGYAOHUANJIE(ZHONGZIYAOWUDESHAIXUAN、YOUHUA;YAOWUZAITI、JIXINGDEZHIBEI;YAOWUDEANQUANXING、YOUXIAOXINGDECESHI),BINGCHANGSHIBANAMISHENGWUCAILIAOZUOWEIYANYAOWUZAITI,CONGYAOLIXUE、YAOXIAOXUEDUOFANGMIANKAOLV,ZAIBAOZHENGZHILIAOXIAOGUODETONGSHI,JIANGDIYAOWUSHIYONGDEFUZAXING,LITUYIDIYANYEHUOKOUFUPIANJIDEXINGSHIJIYAOZHILIAOYANDIJIBING,CONGERFANGBIANGUANGDAHUANZHE。”

  XUHEPINGJIAOSHOUZAISHIYANSHIZUOKEYAN

  欧科瑟(OcuTher)项目在研发新的、有效的视网膜疾病药物的同时,还对15名早期研究人员进行多学科、跨部门的精英专业教育。在有望解决视网膜疾病治疗困境的同时,希望能助力全球跨学科药物研发人员的培养。徐和平教授强调,“值得骄傲的是,这15名接受跨学科精英教育的学生中,有一位是来自中国的学生。”

  JINNIAN7YUEFABUDEXINZHONGGUOCHENGLI70ZHOUNIANJINGJISHEHUIFAZHANCHENGJIUBAOGAOXIANSHI,XINZHONGGUOCHENGLI70NIANLAI,WOGUOKEJISHILIBANSUIZHEJINGJIFAZHANTONGBUZHUANGDA,SHIXIANLECONGNANYIWANGQIXIANGBEIDAOGENPAO、BINGPAONAIZHILINGPAODELISHIXINGKUAYUE,ZHONGGUOZHENGXIANGZHESHIJIEKEJIQIANGGUODEHONGWEIMUBIAOKUOBUQIANJIN,AIERYANKEZAIZHEIGEGUOCHENGZHONGYEYIZHIZAICHIXUFALI。

  爱尔眼科“产学研”一体化

  促科研成果转化造福大众

重庆欢乐生肖  LISHI5NIANYANZHICHUJINSHIYANXINGWEIKEGUANJIANCEYUGANYUDERENGONGZHINENGKECHUANDAISHEBEI“YUNJIA”,YIQIZUOWEIGUANJIANSHIYANSHEBEIQIANTOUYOUZHONGGUOTUANDUIZHUDAODELIUDAZHOUJINSHIYANDASHUJUDUOZHONGXINYANJIUXIANGMU、LIANSHOUKEJIJUTOUYINGTEERDAZAORENGONGZHINENGZHENDUANXITONGDENG,ZUOWEIZHEIXIEGAOKEJICHENGGUO、XIANGMUDEYANFAFANG、ZHUDAOZHE,AIERYANKEYIZHIFEICHANGZHONGSHIKEJICHUANGXINDEFAZHAN。

  近年来,爱尔还通过成立“两院”(中南大学爱尔眼科学院、湖北科技学院爱尔眼视光学院);“七所”(爱尔眼科研究所、眼视光研究所、角膜病研究所、屈光研究所、青光眼研究所、视网膜研究所、武汉爱尔眼科研究所);“一站”(院士专家工作站);“一中心”(博士后科研流动站协作研发中心),开展“光子计划”、“博才班”、“优才计划”,重庆欢乐生肖搭建立体化多层次的人才培养体系,为中国眼科行业不断输送高端人才。

  除此之外,爱尔眼科还积极引进国内外眼科专家大咖,除了徐和平教授加盟中南大学爱尔眼科学院外,中南大学爱尔眼科学院还聘请了包括中国科学院杨雄里院士、苏国辉院士,国际知名的西班牙穆尔西亚大学光学终身教授Pablo Artal教授、伦敦Moorfields眼科医院的Alan Bird(英国)教授、宾夕法尼亚大学医学院的Alexander J.Brucker(美国)教授、约翰霍普金斯医院威尔玛眼科研究所的Neil M.Bressler(美国)教授、国际眼科理事会的Veit-Peter Gabel(德国)教授、芝加哥伊利诺大学的William F.Mieler(美国)教授等国际知名的数十位著名眼科专家出任荣誉、客座教授。

重庆欢乐生肖  XUHEPINGJIAOSHOUBIAOSHI:“CONGYILINCHUANGDAOXIANGWEIZHUDEJICHUYANJIU,DAOLINCHUANGZHUANHUAYANJIU,ZAIDAOLINCHUANGXINJISHUJIFANGFADEYINGYONGYANJIUYULINCHUANGDUOZHONGXINYANJIU,ZUIHOUTONGGUOAIERQUANQIUKEJICHUANGXINFUHUAJIJINDUIKEJICHENGGUOJINXINGZHUANHUA,JIANGNENGGOUGENGKUAIDESHIXIANCONGKEYANDAOCHENGGUODELUODI,ZHENZHENGZAOFUHUANZHE。AIERYANKEWUYISHIZUOYANKEKEYANDEYIPIANWOTU!”

重庆欢乐生肖  ZAIRENCAIPEIYANGHERENCAIYINJINFANGMIAN,AIERYANKEBUYIYULI。ZAIBUDUANKUOZHANYANJIANKANGFUWUQUYUHETISHENGYANJIANKANGFUWUSHUIPINGFANGMIAN,AIERYANKEYELIZHENGSHANGYOU。ZI2002NIANCHENGLI,AIERYANKEBUJUQUANGUOZHONGXINCHENGSHIJISHENGHUI、DIXIANJIYIYUAN、MENZHENBU、SHEQUAIYANeZHANFUWUWANGDIAN,KAICHUANGZHONGGUOYANKEFENJILIANSUOXINMOSHI,BINGTONGGUOSHOUGOUBEIMEIZHOUMING WANGYANKEZHONGXIN(MEIGUO)、OUZHOUBAFALIYAYANKEJITUAN,YIJUCHENGWEIQUANQIUZHUMINGLIANSUOYANKEFUWUJIGOU。

  JINRIAIERYANKEZAIFAGONGGAO,NISHOUGOUDONGNANYAISECYANKEJITUAN,ZHICI,AIERYANKEZHUANYEYANKELIANSUOJIGOUBIANBUYAMEIOUSANDAZHOU,ZHUANYEYANKEJIGOUSHULIANGCHAO500JIA,ZHENZHENGZUODAOLE“GONGXIANGQUANQIUYANKEZHIHUI”。TONGSHI,HAITONGGUOYUYIGUOJIYANKELISHIHUI(ICO)、XINJIAPOGUOLIYANKEYANJIUSUO、Bascom Palmer(BASIKANG·PAERMA)、Wilmer(WEIERMA)、Doheny(DUOXINI)WEIDAIBIAODEYANKEJIGOUJIANLIQUANMIANHEZUOJIZHI,ZHENZHENGDATONGGUOJIHEZUOZIYUANYUQUDAO。

  AIERYANKEDONGSHIZHANGCHENBANGBIAOSHI,“ZHONGQINGHUANLESHENGXIAOJIUSHIXIWANGTONGGUORENCAIPEIYANG、KEYANCHUANGXIN、LINCHUANGZHUANHUAHEGUOJIHUAPINGTAIZHIJIANDELIANGXINGHUDONG,TONGGUOGOUJIANYIFENJILIANSUOSHENGTAI、TONGCHENGWANGLUOSHENGTAI、“HULIANWANG+”SHENGTAI、QUANQIUHUASHENGTAI、YILIAOJINRONGSHENGTAIWUDABANKUAIWEIZHUDEYANJIANKANGSHENGTAIQUAN,BUDUANTUIDONGZHONGGUOYANKERENCAIDEFAZHAN,CUJINZHONGGUOYANKESHIYEDEJINBU,WEIRENLEIYANKEXUEKEJICHUANGXINZUOCHUAIERRENDEGONGXIAN,CONGERSHIXIAN‘SHISUOYOUREN,WULUNPINQIONGFUYU,DOUXIANGYOUYANJIANKANGDEQUANLI’DESHIMING!”

微信关注aierhospital
爱眼护眼早知道
爱尔眼健康社区
扫码注册送积分
重庆欢乐生肖